SG Americas Securities, LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2021$2,288,000
-36.9%
270,458
-9.0%
0.01%
-35.3%
Q2 2021$3,624,000
+583.8%
297,310
+1262.1%
0.02%
+466.7%
Q1 2021$530,000
+53.6%
21,828
+102.6%
0.00%
+50.0%
Q4 2020$345,000
-77.3%
10,775
-78.6%
0.00%
-80.0%
Q3 2020$1,521,000
+384.4%
50,325
+576.3%
0.01%
+233.3%
Q2 2020$314,000
+196.2%
7,441
+74.5%
0.00%
+200.0%
Q1 2020$106,0004,2650.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders